ClinicalTrials.gg
Enrolling by invitationNCT06696040Updated May 14, 2026

Immediate Effects On Gait and Spasticity After The Use Of Passive Kinesiotherapy Equipment In The Lower Limbs Of Neurological Patients

An interventional study of Passive mobilization using a device in Hemiparesis, Paraparesis and Tetraparesis, sponsored by Fernanda Trubian. Enrolling by invitation at 1 site in Brazil. Open to participants aged 9 Years and older. Per ClinicalTrials.gov, last updated 2026-05-14.

Primary conditionParaparesisRegistry: ParesisReclassifiedWhy we changed it
Registry
Paresis — the first condition term the registry derived for this study.
ClinicalTrials.gg
Paraparesis
Why
  1. The study's listed conditions name Paraparesis, a narrower term within Paresis.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Fernanda Trubian · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Non-randomized
Ages
9 Years and older
Sex
All
01

Study summary

Undergo assessment of muscle tone (Ashworth Scale), gait (BAIOBIT) and risk of falling (Timed Up and Go) before using the device; Use the device on the spastic lower limb(s) for 30 minutes; Go through the same assessment carried out previously.

02

Conditions studied

  • Hemiparesis
  • Paraparesis
  • Tetraparesis
  • Cerebral Palsy
  • Spastic Gait
  • Spasticity

Keywords

  • Gait
  • Spasticity
  • Passive Kinesiotherapy
  • Spastic Gait
  • Passive mobilization device
03

In context

Paraparesis Reclassified

7 studies on the registry are indexed under Paraparesis; 3 are open to participants now.

Browse Paraparesis studies →

Lead sponsor

This is the only study on the registry with Fernanda Trubian as lead sponsor.

Compared within Paraparesis, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Paresis. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
9 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • agree and sign the Free and Form or signature of the person responsible
  • individuals with spasiticity (hemiparetic, paraparetic, tetraparetic and hemiparetic children with cerebral palsy)

Exclusion criteria

Exclusion Criteria:

  • over 18 years old whose ability to sign the Free and Form is compromised, or who understand it, but are not responsible for signing the Free and Informed Consent Form
  • present cardiovascular, neurological, musculoskeletal instability or other condition(s) that interfere with the use or positioning of the device or gait assessment
  • present cognitive deficits that interfere with understanding the ICF and/or understanding how to carry out the protocol
  • For the children's group, participants who: 1) are under 8 years of age and/or over 13 years of age will be excluded; 2) no person responsible for signing the TCLE; 3) present cognitive deficits that interfere with understanding the ICF and/or understanding how to carry out the protocol
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Pre-intervention and immediate post-intervention

    Device: Passive mobilization using a device

Interventions

  • DevicePassive mobilization using a device

    The protocol consists of three moments: initial assessment, use of the device, and final assessment. In the initial assessment, participants will be positioned supine on a stretcher, where the muscle tone of the lower limb(s) will be tested using the Modified Ashworth Scale. After the physical test with the Modified Ashworth Scale, the TUG test will be carried out, and, finally, gait assessment with the BAIOBIT Inertial Meter with Accelerometer and Gyroscope. At the end of the initial assessment, the Autofisio500 device will be used. To do this, the participant will be positioned again and comfortably supine on the stretcher, and the previously tested lower limb will be attached to the device for movement, between the knee and ankle joints, for 30 minutes, at maximum speed (11 RPM). For the final assessment, the Modified Ashowrth Scale, TUG and gait assessment with the Inertial Meter with Accelerometer and BAIOBIT Gyroscope will be applied again.

06

What researchers measure

Primary outcomes

  1. Gait kinematics

    Assessment of gait kinematics using the BAIOBIT pre and post intervention

    Time frame: Immediate post-evaluation (after using the device for 30 minutes)

Secondary outcomes

  1. Muscle tone - spasticity

    Time frame: Immediately after using the device for 30 minutes

  2. Timed Up and Go

    Time frame: Immediately after using the device for 30 minutes

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — Participants in this study will have their identities preserved, information from this research will be treated confidentially and confidentially by the responsible researchers and their direct collaborators. All data will be made anonymous (that is, it will only contain your participation number in the study, but not your name) and only these researchers will be able to handle this database. This ensures the privacy and confidentiality of participant data in any publication of results. The data will be stored in a file, under the custody of the responsible researcher, for 5 (five) years, containing individual files.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06696040
Lead sponsor
Fernanda Trubian
Responsible party
Fernanda Trubian (PhD student in Health Sciences, Universidade de Caxias do Sul) — Sponsor-investigator
First posted
Nov 19, 2024
Start date
Mar 1, 2025
Primary completion
May 31, 2028 (estimated)
Completion
Jul 31, 2028 (estimated)
Last update
May 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion